SELLAS Life Sciences Group, Inc. (SLS)

4.69 -0.05 (-1.05%) USD  |  NASDAQ  |  Feb 25, 12:59
More

SELLAS Life Sciences Group Preferred Securities out of Shareholders Equity (Quarterly)

Preferred Securities out of Shareholders Equity (Quarterly) Chart

View Preferred Securities out of Shareholders Equity (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Securities out of Shareholders Equity (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --